Effect of Lower Limb Constraint Induced Movement Therapy Using a Torque-Assisted Exoskeletal Wear… (NCT06830707) | Clinical Trial Compass
CompletedNot Applicable
Effect of Lower Limb Constraint Induced Movement Therapy Using a Torque-Assisted Exoskeletal Wearable Device
South Korea16 participantsStarted 2023-07-13
Plain-language summary
The aim of this study was to investigate the effects of lower limb constraint induced motor therapy using the robotic rehabilitation device on ambulatory function in chronic stroke patients.
Who can participate
Age range
19 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 19 years or older
* Patients with hemiparesis due to ischemic or hemorrhagic stroke
* Patients in the late subacute or chronic phase, at least 3 months after the onset of stroke
* Individuals who can independently walk with a Functional Ambulatory Category score of 3 or higher
* Patients who are able to use Torque-Assisted Exoskeletal Wearable Device Height: 140 cm to 190 cm Weight: 80 kg or less Shoe size: 230 mm to 290 mm
* Patients who were independent walkers and had no difficulties performing activities of daily living (mRS ≤ 1)
Exclusion Criteria:
* Patients with severe cognitive impairment (MMSE \<10) or significant communication difficulties such as speech disorders
* Patients with spasticity in one-sided lower limbs, rated 2 or higher on the Modified Ashworth Scale (MAS)
* Patients with severe musculoskeletal disorders of the lower limbs
* Patients with contractures that limit the range of motion in the lower limbs
* Patients with an apparent leg length discrepancy of 2 cm or more
* Patients with fractures, open trauma, or non-healing ulcers in the lower limbs
* Patients with serious internal diseases such as cardiovascular disease or pulmonary disease that make it difficult to use Exoskeletal Wearable Device for walking therapy
* Patients with a history of osteoporotic fractures
* Patients with other neurological disorders affecting walking (e.g., Parkinson's disease, multiple sclerosis, etc.)
* Any other cases where the investig…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.